BACKGROUND: The objective of this study was to determine the rate and pattern of nodal recurrence in patients who underwent a therapeutic, lateral neck dissection (LND) for papillary thyroid cancer (PTC) with clinically evident cervical metastases and to determine if there was any correlation between the extent of initial dissection and the rate and pattern of neck recurrence. METHODS: A total of 3,664 patients with PTC treated between 1986 and 2010 at Memorial Sloan Kettering Cancer Center were identified from our institutional database. Tumor factors, patient demographics, extent of initial LND, and adjuvant therapy were recorded. Patterns of recurrent lateral neck metastases by level involvement were recorded and outcomes calculated using the Kaplan-Meier method. RESULTS: A total of 484 patients had an LND for cervical metastases; 364 (75%) had a comprehensive LND (CLND) and 120 (25%) had a selective neck dissection (SND). The median duration of follow-up was 63.5 months. As expected, patients with CLND had a greater number of nodes removed as well as a greater number of positive nodes (P < .001). There was no difference in overall lateral neck recurrence-free status (CLND 94.4% vs SND 89.4%, P = .158), but in the dissected neck, the ipsilateral lateral neck recurrence-free status was superior in the CLND patients (97.7% vs 89.4%, P < .001). CONCLUSION: Patients with clinically evident neck metastases from PTC managed by CLND have lesser rates of recurrence in the dissected neck compared with patients managed by SND. SND should only be done in highly selected cases with small volume disease.
BACKGROUND: The objective of this study was to determine the rate and pattern of nodal recurrence in patients who underwent a therapeutic, lateral neck dissection (LND) for papillary thyroid cancer (PTC) with clinically evident cervical metastases and to determine if there was any correlation between the extent of initial dissection and the rate and pattern of neck recurrence. METHODS: A total of 3,664 patients with PTC treated between 1986 and 2010 at Memorial Sloan Kettering Cancer Center were identified from our institutional database. Tumor factors, patient demographics, extent of initial LND, and adjuvant therapy were recorded. Patterns of recurrent lateral neck metastases by level involvement were recorded and outcomes calculated using the Kaplan-Meier method. RESULTS: A total of 484 patients had an LND for cervical metastases; 364 (75%) had a comprehensive LND (CLND) and 120 (25%) had a selective neck dissection (SND). The median duration of follow-up was 63.5 months. As expected, patients with CLND had a greater number of nodes removed as well as a greater number of positive nodes (P < .001). There was no difference in overall lateral neck recurrence-free status (CLND 94.4% vs SND 89.4%, P = .158), but in the dissected neck, the ipsilateral lateral neck recurrence-free status was superior in the CLND patients (97.7% vs 89.4%, P < .001). CONCLUSION:Patients with clinically evident neck metastases from PTC managed by CLND have lesser rates of recurrence in the dissected neck compared with patients managed by SND. SND should only be done in highly selected cases with small volume disease.
Authors: C P van Wilgen; P U Dijkstra; B F A M van der Laan; J T Plukker; J L N Roodenburg Journal: Br J Oral Maxillofac Surg Date: 2003-02 Impact factor: 1.651
Authors: Avi Khafif; Jesus E Medina; K Thomas Robbins; Carl E Silver; Randal S Weber; Alessandra Rinaldo; Randall P Owen; Ashok R Shaha; Alfio Ferlito Journal: Head Neck Date: 2012-01-27 Impact factor: 3.147
Authors: J E Terrell; D E Welsh; C R Bradford; D B Chepeha; R M Esclamado; N D Hogikyan; G T Wolf Journal: Laryngoscope Date: 2000-04 Impact factor: 3.325
Authors: Michael E Kupferman; Michael Patterson; Susan J Mandel; Virginia LiVolsi; Randal S Weber Journal: Arch Otolaryngol Head Neck Surg Date: 2004-07
Authors: Michael E Kupferman; D Michael Patterson; Susan J Mandel; Virginia LiVolsi; Randal S Weber Journal: Laryngoscope Date: 2004-03 Impact factor: 3.325
Authors: Ashok R Shaha; Jocelyn C Migliacci; Iain J Nixon; Laura Y Wang; Richard J Wong; Luc G T Morris; Snehal G Patel; Jatin P Shah; R Michael Tuttle; Ian Ganly Journal: Surgery Date: 2018-11-08 Impact factor: 3.982
Authors: Hélène Bohec; Ingrid Breuskin; Julien Hadoux; Martin Schlumberger; Sophie Leboulleux; Dana M Hartl Journal: World J Surg Date: 2019-03 Impact factor: 3.352
Authors: Emilien Chebib; Caroline Eymerit; Nathalie Chabbert-Buffet; Bruno Angelard; Jean Lacau St Guily; Sophie Périé Journal: Gland Surg Date: 2020-12
Authors: Suvi Renkonen; Riikka Lindén; Leif Bäck; Robert Silén; Hanna Mäenpää; Laura Tapiovaara; Katri Aro Journal: Eur Arch Otorhinolaryngol Date: 2017-09-02 Impact factor: 2.503